The future of pharmacologic stress: selective A2A adenosine receptor agonists.
about
Suppression of inflammatory and immune responses by the A(2A) adenosine receptor: an introduction.Coronary microvascular dysfunction in women with nonobstructive ischemic heart disease as assessed by positron emission tomographyDirect or indirect stimulation of adenosine A2A receptors enhances bone regeneration as well as bone morphogenetic protein-2.A randomized, double-blind, placebo-controlled study of the safety and tolerance of regadenoson in subjects with stage 3 or 4 chronic kidney disease.Fractional flow reserve in 2017: current data and everyday practice.Regadenoson in the detection of coronary artery disease.The role of mitochondrial and plasma membrane nucleoside transporters in drug toxicity.Therapeutic potential of adenosine receptor antagonists and agonists.Selective adenosine agonists and myocardial perfusion imaging.Structure-Activity Relationships of the Sustained Effects of Adenosine A2A Receptor Agonists Driven by Slow Dissociation Kinetics.Impact of pharmacological stress agent on patient motion during rubidium-82 myocardial perfusion PET/CT.Regadenoson in Myocardial Perfusion Study - First Institutional Experiences in Bosnia and Herzegovina.Adenosine A2A receptor signaling regulation of cardiac NADPH oxidase activity.Safety of regadenoson as a pharmacologic stress agent for myocardial perfusion imaging in chronic kidney disease patients not on hemodialysis.Regadenoson provides perfusion results comparable to adenosine in heterogeneous patient populations: a quantitative analysis from the ADVANCE MPI trials.Regadenoson, a novel pharmacologic stress agent for use in myocardial perfusion imaging, does not have a direct effect on the QT interval in conscious dogs.Influence of adenosine on ventricular function measurements as part of a comprehensive stress perfusion magnetic resonance imaging study.Effects of Caffeine on Myocardial Blood Flow: A Systematic Review
P2860
Q30440124-7A4C1B7F-79DF-4EA6-806E-0A426C05319CQ33651077-DBC0810B-C5BA-4931-B061-AB6B72252E1CQ35410561-15B42592-BD72-4559-90FE-A19C150FC925Q35904476-C4729567-3617-4FFC-BDA0-600450845967Q36364120-45045175-EB97-49B4-9689-6EDFA59C1EBBQ36812777-E059A6C7-04C2-45F0-AC2B-9C38CBC70C3CQ36960546-C9B07491-2171-44D5-A236-7B10A21A167BQ37689793-ADEA7B43-97E0-4081-A372-00E24A33C4DBQ37963279-68CAB47A-5A91-4E35-B4F3-D51CC9DD115EQ38734217-2AACAF13-625D-4940-9BB5-2EE5E30530DDQ39039182-22095CE7-665E-48C1-90D2-AB7AE378654BQ40445363-DBB36DE8-370F-4CE7-A43D-BE6B9F2F48ABQ41268608-C1301B54-278A-4138-AAB9-DF92C9E5A0ACQ44116521-3DFF1447-BBAE-4003-A550-CCDAB30F9CD5Q45833492-031E1B03-8C38-48A4-BDCC-49A6ADF2A523Q46223667-E22E6125-012F-466D-92BD-6F6F7C2C826EQ46739441-293E0153-131B-4062-B753-2A0EE31E7C03Q58784777-D04E3EBA-D5E7-4C98-B6D1-8F2AC9EBD496
P2860
The future of pharmacologic stress: selective A2A adenosine receptor agonists.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
The future of pharmacologic stress: selective A2A adenosine receptor agonists.
@en
The future of pharmacologic stress: selective A2A adenosine receptor agonists.
@nl
type
label
The future of pharmacologic stress: selective A2A adenosine receptor agonists.
@en
The future of pharmacologic stress: selective A2A adenosine receptor agonists.
@nl
prefLabel
The future of pharmacologic stress: selective A2A adenosine receptor agonists.
@en
The future of pharmacologic stress: selective A2A adenosine receptor agonists.
@nl
P1476
The future of pharmacologic stress: selective A2A adenosine receptor agonists.
@en
P2093
Manuel D Cerqueira
P304
33D-40D; discussion 40D-42D
P356
10.1016/J.AMJCARD.2004.04.017
P407
P577
2004-07-01T00:00:00Z